BioCryst's ORLADEYO nabs CHMP positive recommendation in hereditary angioedema
26 February 2021 - 8:26AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
BioCryst Pharmaceuticals (NASDAQ:BCRX)
Historical Stock Chart
From Apr 2024 to May 2024
BioCryst Pharmaceuticals (NASDAQ:BCRX)
Historical Stock Chart
From May 2023 to May 2024